Febit to Launch New Analyzer as Boston Lab Preps for R&D Work; Eyes SF Expansion | GenomeWeb
Febit plans to augment its array hardware portfolio by launching a lower-cost analyzer in the second quarter, followed by a hybridization station in the future, a company official said last week.
The Heidelberg, Germany-based company may also open a lab in California if its first US facility in Boston, which opened last year, is successful.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.